Navigation Links
CRN Emphasizes Importance of Folic Acid Benefits

WASHINGTON, The Council for Responsible Nutrition (CRN) today responded to a study and accompanying editorial on folic acid and the prevention of cancer in the June 6 issue of the Journal of the American Medical Association (JAMA) by urging the scientific research community, the media, and the government not to jump to conclusions that would undo the important strides made in recent years in encouraging supplementation and food fortification with folic acid.

"The benefits of folic acid are well-documented, particularly in the area of reducing the risk of neural tube birth defects," said Andrew Shao, Ph.D., vice president, scientific and regulatory affairs, CRN. "There is also promising scientific evidence for folic acid in reducing the risk of congenital cardiovascular defects, stroke, and Alzheimer's disease. It would be a huge public disservice potentially resulting in extremely negative health consequences if scientists, the media or government rushed to judgment based on this study."

CRN noted that the study, which found that folic acid did not prevent the incidence of benign tumors (colorectal adenomas) in patients with a history of tumors, was conducted in response to epidemiological studies showing a potential benefit. The lack of an observed benefit in this study may have resulted because folic acid was used like a drug to treat pre-existing disease, rather than as a nutrient. "It's not surprising that folic acid alone may not prevent the recurrence of adenomas," said Dr. Shao. "Perhaps in combination with other related nutrients or in subjects without previous adenomas we would have seen more promising results, confirming what was suggested from earlier research."

In examining the secondary results of the study, which hinted at the possibility that an over abundance of folic acid might promote cancer cells in those who already have cancer, the editorial noted the "dual effect" that refers to other previous research on folic acid which found protection against development of cancer.

Dr. Shao noted he supported the researchers' call for further research to determine the validity and potential reasons behind their findings, but emphasized that the findings involved a relatively small number of diseased subjects, limiting the generalizability of the results to the generally healthy population. "Consumers can still feel they are doing something good by supplementing or fortifying with folic acid," he noted.

The trial used 1,000 micrograms (mcg) of folic acid per day which is the tolerable upper intake level (UL), but not the recommended intake. Most multivitamins contain between 200 and 400 mcg per serving, for consumption on a daily basis. Combined with food fortification, which is estimated to provide up to 120 mcg per day of folic acid, the American population is still consuming well below the UL for folic acid.

CRN noted the study authors indicated their findings were "equivocal" and that even the accompanying editorial stated, "the question of folate in cancer prevention is not resolved."

"This study is an interesting addition to the current scientific literature, and more research should be done. In the meantime, consumers should not deprive themselves of the known benefits of folic acid."

CRN reminds anyone who has colon cancer (or any other cancer) or is at high risk for the disease, to consult a healthcare professional to determine the best course of action.


'"/>




Related medicine news :

1. FDA Re-Emphasizes Warnings to Consumers on Risks of Pet Turtles
2. Importance of Fatty food In Hypercholestrolemia
3. Importance of soy protein in your diet
4. Importance of type of sex in organ transplantation
5. Importance of An Active Lifestyle
6. Importance of An Active Lifestyle
7. The Importance Of “ Good ”Control Of Diabetes During Pregnanc
8. The Importance Of Skin Cancer Screening
9. The Importance Of Folic Acid Supplements
10. The Importance Of Vitamin D Supplements
11. More Importance To Be Given To Prenatal Nutrition
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... 2017 , ... Doctor C LLC, a company based out of Arizona that ... continue the marketing and distribution of its product, The Right C. , The Right ... absorption than traditional vitamin C supplements. At the trade show, Doctor C had the ...
(Date:1/20/2017)... ... , ... International Protein, a company based out of Australia that focuses on ... ECRM trade show in Hilton Head, SC. , International Protein was founded by ... line of products that would elevate her fitness regime. At this ECRM trade show, ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Mary Magdalene: Grace ... mysterious life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is ... who spent her career as an educator interacting with countless women who had little ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in a study ... Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive Expiratory Pressure ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “The Land ... brings attention to the issue of world hunger, and shares the simple and achievable ... Brubaker, devoted husband and member of the Fairview Missionary Church in Angola, Indiana where ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 The U.S. Food and ... Chronic Idiopathic Constipation (CIC) in adult patients. ... gastrointestinal disorders," said Julie Beitz , M.D., director of ... for Drug Evaluation and Research. "With the availability of new ... treatment for their condition." ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 Agonists, ... Others The global anti-obesity drugs market is ... half of the forecast period and CAGR of 38.7% in the ... grow at a CAGR of 32.8% from 2016 to 2027. The ... 2021, and $24,063 million in 2027. ...
Breaking Medicine Technology: